Age-specific distributions of cytogenetic subgroups of acute myeloid leukemia: Data analysis in a Chinese population

Acta Haematologica

Volumn 129, Issue 3, 2013, Pages 175-181

  Su, Long ^a   Gao, Sujun ^a   Li, Wei ^a   Tan, Yehui ^a   Yang, Lei ^a   Liu, Ziling ^a   Bai, Ou ^a   Yang, Yan ^a   Yao, Cheng ^a   Song, Yanqiu ^a   Wang, Guanjun ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Acute myeloid leukemia; Age; Cytogenetics; Molecular markers

Indexed keywords

CD135 ANTIGEN; NUCLEOPHOSMIN; STEM CELL FACTOR; MOLECULAR MARKER; FLT3 PROTEIN, HUMAN; NUCLEAR PROTEIN; STEM CELL FACTOR RECEPTOR; TUMOR MARKER;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CHINESE; CYTOGENETICS; FEMALE; GENE MUTATION; HUMAN; INCIDENCE; INFANT; KARYOTYPE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONOSOMY; PATIENT CODING; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TRISOMY; BALANCED KARYOTYPE; CANCER CLASSIFICATION; CANCER PREVENTION; COMPLEX KARYOTYPE; DATA ANALYSIS; GENE FREQUENCY; GENE TRANSLOCATION; GROUPS BY AGE; MIDDLE AGED; MONOSOMAL KARYOTYPE; NEWBORN; UNBALANCED KARYOTYPE; YOUNG ADULT; AGE; ASIAN; CHINA; CHROMOSOME ABERRATION; CLINICAL TRIAL; METABOLISM; MULTICENTER STUDY; PATHOLOGY; VERY ELDERLY;

ABNORMAL KARYOTYPE; ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHINA; FEMALE; FMS-LIKE TYROSINE KINASE 3; HUMANS; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS C-KIT; TUMOR MARKERS, BIOLOGICAL;

MLCS; MLOWN;

EID: 84871251577     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000345250     Document Type: Article

References (18)

1. Moorman AV, Roman E, Willett EV, Dovey GJ, Cartwright RA, Morgan GJ: Karyotype and age in acute myeloid leukemia. Are they linked? Cancer Genet Cytogenet 2001; 126: 155-161 (Pubitemid 32453333)
2. Bacher U, Kern W, Schnittger S, Hiddemann W, Haferlach T, Schoch C: Population-based age-specific incidences of cytogenetic subgroups of acute myeloid leukemia. Haematologica 2005; 90: 1502-1510 (Pubitemid 41658763)
3. Schoch C, Haferlach T: Cytogenetics in acute myeloid leukemia. Curr Oncol Rep 2002; 4: 390-397
4. Breems DA, Van Putten WL, De Greef GE, Van Zelderen-Bhola SL, Gerssen-Schoorl KB, Mellink CH, Nieuwint A, Jotterand M, Hagemeijer A, Beverloo HB, Löwenberg B: Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype. J Clin Oncol 2008; 26: 4791-4797
5. Medeiros BC, Othus M, Fang M, Roulston D, Appelbaum FR: Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experience. Blood 2010; 116: 2224-2228
6. Foran JM: New prognostic markers in acute myeloid leukemia: perspective from the clinic. Hematology Am Soc Hematol Educ Program 2010; 2010: 47-55
7. Gilliland DG, Griffin JD: The roles of FLT3 in hematopoiesis and leukemia. Blood 2002; 100: 1532-1542 (Pubitemid 34925124)
8. Schlenk RF, Döhner K, Krauter J, Fröhling S, Corbacioglu A, Bullinger L, Habdank M, Späth D, Morgan M, Benner A, Schlegelberger B, Heil G, Ganser A, Döhner H; German- Austrian Acute Myeloid Leukemia Study Group: Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med 2008; 358: 1909-1918 (Pubitemid 351620111)
9. Rulina AV, Spirin PV, Prassolov VS: Activated leukemic oncogenes AML1-ETO and ckit: role in development of acute myeloid leukemia and current approaches for their inhibition. Biochemistry (Mosc) 2010; 75: 1650-1666
10. Gritsaev SV, Martynkevich IS, Martynenko LS, Ivanova MP, Aksenova V, Moskalenko MV, Zapreeva IM, Abdulkadyrov KM: Agespecific characteristics of acute myeloid leukemia karyotype (in Russian). Ter Arkh 2011; 83: 51-55
11. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, Rees J, Hann I, Stevens R, Burnett A, Goldstone A: The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998; 92: 2322-2333 (Pubitemid 28452973)
12. Schneider F, Hoster E, Schneider S, Dufour A, Benthaus T, Kakadia PM, Bohlander SK, Braess J, Heinecke A, Sauerland MC, Berdel WE, Buechner T, Woermann BJ, Feuring- Buske M, Buske C, Creutzig U, Thiede C, Zwaan MC, van den Heuvel-Eibrink MM, Reinhardt D, Hiddemann W, Spiekermann K: Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML). Ann Hematol 2012; 91: 9-18
13. Shaffer LG, Slovak ML, Campbell LJ (eds): ISCN 2009: An International System for Human Cytogenetic Nomenclature (2009). Basel, Karger, 2009
14. Harrison CJ, Hills RK, Moorman AV, Grimwade DJ, Hann I, Webb DK, Wheatley K, de Graaf SS, van den Berg E, Burnett AK, Gibson BE: Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12. J Clin Oncol 2010; 28: 2674-2681
15. So CC, Wan TS, Chow JL, Hui KC, Choi WW, Lam CC: A single-center cytogenetic study of 629 Chinese patients with de novo acute myeloid leukemia - evidence of major ethnic differences and a high prevalence of acute promyelocytic leukemia in Chinese patients. Cancer Genet 2011; 204: 430-438
16. de Jonge HJ, Valk PJ, de Bont ES, Schuringa JJ, Ossenkoppele G, Vellenga E, Huls G: Prognostic impact of white blood cell count in intermediate risk acute myeloid leukemia: relevance of mutated NPM1 and FLT3-ITD. Haematologica 2011; 96: 1310-1317
17. Haferlach T, Bacher U, Alpermann T, Haferlach C, Kern W, Schnittger S: Amount of bone marrow blasts is strongly correlated to NPM1 and FLT3-ITD mutation rate in AML with normal karyotype. Leuk Res 2012; 36: 51-58
18. Schoch C, Kern W, Krawitz P, Dugas M, Schnittger S, Haferlach T, Hiddemann W: Dependence of age-specific incidence of acute myeloid leukemia on karyotype. Blood 2001; 98: 3500.